Taiwanese Manufacturer Cited for Multiple Violations By Sam | September 14, 2018 The FDA flagged UBI Pharma for a slew of violations at its Hsinchu County, Taiwan, facility including inadequate environmental monitoring and sterility practices. Source: Drug Industry Daily Posted in Drug Industry Daily